While India is still witnessing rapid surge in dreaded Covid 19 cases with nearly fifty thousand cases daily at the pan India level it has crossed 13 lakh infections being third in the world after United States n Brazil.
So far India has the tally of more than thirty thousand Covid 19 fatalities though with a good recovery rate of more than 62 percent nationally. Meanwhile there is a good news about starting of the human trials in the biggest medical institute of the country viz All India Institute of Medical Sciences after its ethics committee gave the clearance for human trials Phase 1 n 2.
On Friday the first trial was done on a healthy thirty year old man by injecting the Covaxin vaccine candidate and observing the results. Everything went well as there were no side effects, especially the negative ones.
The human trials of the Covaxin vaccine candidate, a joint venture of Indian Council of Medical Research’s National Institute of Virology and Hyderabad based Bharat Biotech are being conducted on healthy humans from the age of 18 to 55 with no comorbiditis including ( no) Covid 19 infection. Two other of the twelve human trial centres at Patna n Rohtak have also administered the vaccine in humans.
According to various news reports these long awaited human trials that will go on in phase 1, Phase 2 n 3 has yesterday started with administration of the Covaxin injection on a thirty year old healthy young man, devoid of any comorbiditis, who have been selected out of one hundred selections chosen from total 3500 applicants who’d voluntarily applied for Covid 19 Covaxin vaccine candidates’ human trials.
The response in the AIIMS was phenomenal. Those on human trials would be monitored on the first day, for seven days thereafter on 14th day n then on 28 th day.
In order to keep track of any long term side affects these human trial incumbents would be under observation from six months to a year, which probably means that the anti Covid vaccine will at least take more than a year to the minimum to come out in the market.
These human trials are primarily testing the immunogenicity n safety of the vaccine in humans ranging from the age of 18 years to 55.
According to Professor of Community medicines n one of the investigators of the trial Dr. PUNEET Mishra the safety of the humans on the trials is of foremost significance n therefore the priority is to do these trials on healthy people who are bound to go under various tests before finally being selected as a suitable candidate for these human trials.
They need to be completely healthy with no comorbiditis n and Covid 19 negative. There have been about 150 to 175 Anti Covid 19 vaccine candidates worldwide undergoing trials on animals n humans n some in near completion stages with the likes of Oxford’s Astra Zeneca n Moderna etc undergoing human trials in US n UK.
Apart from these vaccine candidates human trials are also going on in Russia on two vaccine candidates one developed by Russian Defense ministry n private company n another by the Sekhenov University. US, UK, Germany, Canada,Brazil, India etc are hectically involved in devising the anti Covid 19 vaccines hoping to come out in a year’s time.
Picture below n above Healthwire
